Licensing opportunity from the NIH: method of inhibiting HGF/SF cleavage, activation Nov. 5, 1998 No Comments
Irreversible inactivators of EGF receptor TK hold promise as antitumor agents Nov. 5, 1998 No Comments
NAALADase inhibitors now reported to be useful for prostate cancer; patents issued Nov. 3, 1998 No Comments
Mitomycin C derivative shows therapeutic potential in treating bladder carcinoma Nov. 3, 1998 No Comments
Impressive results obtained with C225 in combination with radiotherapy in head and neck cancer Nov. 3, 1998 No Comments
Successful completion of phase I/II clinical trial of VIMRxyn in brain cancer Oct. 30, 1998 No Comments